SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-018764
Filing Date
2021-04-14
Accepted
2021-04-14 07:05:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A glto-defa14a_20210414.htm DEFA14A 29304
2 GRAPHIC gp5oom2n3nws000002.jpg GRAPHIC 101146
3 GRAPHIC gp5oom2n3nws000001.jpg GRAPHIC 173628
  Complete submission text file 0001564590-21-018764.txt   409042
Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39655 | Film No.: 21824514
SIC: 2834 Pharmaceutical Preparations